COMPASS Pathways plc (CMPS )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol CMPS
- Company COMPASS Pathways plc
- Price $7.63
- Changes Percentage 31.33
- Change 1.82
- Day Low $7.31
- Day High $8.8
- Year High $8.8
- Year Low $2.25
- Market Cap $732,495,596
- Price Avg 50 EMA (D) $6.66
- Price Avg 200 EMA (D) $5.26
- Exchange NASDAQ
- Volume 34,594,265
- Average Volume 1,361,778
- Open $7.81
- Previous Close $5.81
- EPS -2.72
- PE -2.81
- Earnings Announcement 2026-02-26 12:00:00
- Shares Outstanding $96,002,044
Company brief: COMPASS PATHWAYS PLC (CMPS )
- Healthcare
- Medical - Care Facilities
- Mr. Kabir Kumar Nath M.A., M.B.A.
- https://compasspathways.com
- GB
- N/A
- 09-18-2020
- US20451W1018
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.